La catena delle opzioni mostra i dati chiave delle opzioni azionarie di American Oncology Network a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per American Oncology Network..

American Oncology Network (OTC:AONC) Azioni, Catena delle Opzioni

American Oncology Network

American Oncology Network Inc through its subsidiary companies and variable interest entities, is an alliance of physicians and seasoned healthcare leaders who provide comprehensive oncology services across 37 oncology practices located in twenty states. The Company also provides expertise in drug procurement and payor contracting, along with practice diversification through centralized laboratory and pathology services, as well as specialty pharmacy services, clinical research, radiation oncology, and imaging.

AMER ONCOLOGY NETWORK A by American Oncology Network, Inc.

American Oncology Network Inc

American Oncology Network Inc Warrants (31/03/2028)

News

General

CSWC

Capital Southwest Corporation Announces Prelim Q4 2025 Pre-Tax Net Investment Income $0.55 To $0.56/share; Prelim Q4 2025 Net Investment Income $0.54 To $0.55/share

Citigroup analyst Andrew Kaplowitz maintains GE Vernova (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>) with a Neutral and lowers the price target from $437 to $354.

Price Target

Analyst Ratings

Citigroup Maintains Neutral on GE Vernova, Lowers Price Target to $354

TOMI Environmental Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TOMZ#NASDAQ">TOMZ</a>) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $0.01 by 600 percent. This is a 25 percent decrease over losses of $(0.04) per share from the same period last year. The company reported $1.07 million in sales this quarter. This is a 30.04 percent decrease over sales of $1.53 million the same period last year.

Earnings

Earnings Misses

TOMZ

TOMI Environmental Solns Q4 Adj $(0.05) Misses $0.01 Estimate, Sales $1.07M Down From $1.53M YoY

Citigroup analyst Andrew Kaplowitz maintains Gates Industrial Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GTES#NYSE">GTES</a>) with a Buy and lowers the price target from $27 to $21.

GTES

Citigroup Maintains Buy on Gates Industrial Corp, Lowers Price Target to $21

Macro Economic Events

Economics

Federal Reserve

U.S. Treasury Secretary Bessent Says Thinking About Successor For Fed's Powell, Will Start Interviewing Candidates In The Fall; Asked If Treasury Has Plans To Respond To Bond Market Moves, Says Treasury Has Lots Of Tools, But 'We're A Long Way From That'; Pleasantly Surprised At How Quickly Tax Bill Is Moving Along

Goldman Sachs Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) on Monday reported its first-quarter global banking and markets division revenue rose 10% to $10.71 billion, driven higher by blockbuster equity trading revenue. However, CEO David Solomon warned of uncertainty and potential turbulence ahead on the company's<a href="https://www.benzinga.com/25/04/44791428/goldman-sachs-q1-beats-consensus-equity-ficc-revenues-drive-growth-declares-40b-buyback"> earnings call. </a>
What To Know: The Goldman Sachs CEO warned that the prospect of a recession has increased with <a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44791485/bank-stocks-rebound-above-200-day-average-as-earnings-propel-dip-buyers">global signals</a> indicating a slow down in economic activity. He said that these indicators combined with the potential of an escalating trade war have left the bank's clients with an uncomfortable degree of uncertainty.&nbsp;
Read Next: <a href="https://www.benzinga.com/news/management/25/04/44774273/jpmorgan-ceo-jamie-dimon-expects-sp-500-growth-forecast-to-be-cut">JPMorgan CEO Jamie Dimon Expects S&amp;P 500 Growth Forecast To Be Cut</a>
"This uncertainty around the path forward and fears over the potentially escalating effects of a trade war have created material risks to the U.S. and global economy," Solomon told analysts on the call.&nbsp;
Solomon noted that he hears an even "greater sense of short-term concern" from CEOs located outside of the United States.&nbsp;
He added, however, that he is "encouraged" with the Trump administration's most recent developments including time for negotiations on future trade policies.&nbsp;
JPMorgan Chase &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) CEO Jamie Dimon made <a href="https://www.benzinga.com/news/management/25/04/44774273/jpmorgan-ceo-jamie-dimon-expects-sp-500-growth-forecast-to-be-cut">similar comments</a> last Friday on his company's earnings call that negotiations "would be good for everybody."&nbsp;
Solomon added that clarity on policy should come with time and advised investors and CEOs to "go slow and take a pause here until we have more clarity around a lot of these issues."
GS Price Action: Goldman Sachs shares ended Monday's session 2.09% higher at $504.78, according to data from<a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw"> Benzinga Pro</a>.&nbsp;
Read Next:<a href="https://www.benzinga.com/news/global/25/04/44793519/energy-secretary-chris-wright-is-bullish-as-oil-prices-crater">&nbsp;</a>
<ul>
<li><a href="https://www.benzinga.com/news/global/25/04/44793519/energy-secretary-chris-wright-is-bullish-as-oil-prices-crater">Energy Secretary Chris Wright Is &#8216;Bullish&#8217; As Oil Prices Crater</a> </li>
</ul>
Image: Shutterstock

Management

Movers

Tariff Fears Pose 'Material Risks' To US And Global Economies, Goldman Sachs CEO Warns

WIIM

ALGM

Allegro MicroSystems shares are trading lower after ON Semiconductor withdrew its acquisition proposal.

ON Semiconductor shares are trading higher after the company withdrew its acquisition proposal for Allegro MicroSystems.

GOVX

GeoVax Labs shares are trading lower after the company announced it received a notification from Advanced Technology International to stop all work on its efforts with respect to Project Agreement No. 01; RRPV-24-04-NGVx-006; "NextGen Vaccinations: Phase 2B Clinical Trial Execution: Phase 2b study to evaluate GEO-CM04S1 COVID-19 vaccine"

onsemi Withdraws Proposal To Acquire Allegro MicroSystems For $35.10/Share

After-Hours Center

DECA

Denali Capital Shareholders Approve Deadline Extension To Complete Business Combination

Biotech

GeoVax Directed By Advanced Technology International To Halt Work On Their Phase 2b Clinical Trial For The GEO-CM04S1 COVID-19 Vaccine, As Part Of A Project Funded By U.S. Department Of Health's BARDA Program.

Global

U.S. Treasury Secretary Bessent Says Trump Administration Focused On Latin America, Trying To Prevent What Happened In Africa With China And Its Policies There; U.S. Not Considering A Foreign Exchange Swap With Argentina; Trump, China's Xi Have Very Good Relationship, Tariffs On China Are Big Numbers, No One Thinks They're Sustainable And Wants Them To Remain; Don't Think There's A Dumping Of U.S. Assets In Bond Market

A new report highlights the growth of several automotive brands, as Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) saw its market share decline in the U.S.<a href="https://www.benzinga.com/topic/electric-vehicle"> electric vehicle sector</a> in the first quarter.
What Happened: A political push by Tesla CEO Elon Musk has <a href="https://www.benzinga.com/trading-ideas/25/02/43447273/tesla-sales-drop-12-in-california-is-elon-musks-support-for-donald-trump-hurting-ev-sales">led to protests </a>at Tesla dealerships and lower sales of the leading electric vehicle company in the United States and around the world.
A new Cox Automotive <a href="https://www.coxautoinc.com/market-insights/q1-2025-ev-sales/">report</a>, shared by <a href="https://www.teslarati.com/best-selling-ev-brands-us-q1-2025/">Teslarati</a>, highlights the top-selling electric vehicle companies and models in the United States for the first quarter.
The report estimates that 296,227 electric vehicles were sold in the United States in the first quarter, up 11.4% year over year. According to the report, new EVs made up around 7.5% of the overall U.S. new car sales in the quarter.
For comparison, the overall U.S. EV market sold 1.3 million new vehicles in 2024, a record. That figure was up 7.3% year over year.
Read Also: <a href="https://www.benzinga.com/interview/25/03/44539183/exclusive-tesla-protest-organizer-says-elon-musk-seems-to-have-purchased-the-american-government">EXCLUSIVE: Tesla Protest Organizer Says &#8216;Elon Musk Seems To Have Purchased The American Government&#8217;</a>
Winners and Losers: Tesla remained the U.S. leader by a wide margin, outselling the following top 10 companies combined. However, the EV leader saw its overall U.S. sales down 8.6% year over year.
Here were the top EV sellers in the first quarter by units sold, according to the report:
<ol>
<li>Tesla: 128,100</li>
<li>Ford: 22,500</li>
<li>Chevrolet: 19,186</li>
<li>BMW: 13,538</li>
<li>Hyundai: 12,843</li>
<li>VW: 9,564</li>
<li>Honda: 9,561</li>
<li>Kia: 8,656</li>
<li>Rivian: 8,553</li>
<li>Cadillac: 7,972</li>
</ol>
Ford Motor Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) and General Motors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>), which owns Chevrolet, ranked second and third for the quarter. Ford saw 11.5% overall year-over-year growth in the quarter.
Several of General Motors&#8217; brands saw strong growth, including Chevrolet, which had first-quarter sales up 114.2% year over year.
Porsche led the way as a brand with a 249% year-over-year increase in the first quarter, followed by Toyota (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TM#NYSE">TM</a>) at +196%, GMC at +183, Subaru at 173% and Volvo at +173%.
Outside of Tesla, other decliners included Lexus (-9%), Mini (-16%), Kia (-24%), Rivian Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) (-37%) and Mercedes-Benz (-58%).
These were the top-selling EV models in the U.S. in the quarter:
<ol>
<li>Tesla Model Y: 64,051</li>
<li>Tesla Model 3: 52,520</li>
<li>Ford Mustang Mach-E: 11,607</li>
<li>Chevrolet Equinox EV: 10,329</li>
<li>Honda Prologue: 9,561</li>
<li>Hyundai Ioniq 5: 8,611</li>
<li>VW ID.4: 7,662</li>
<li>Ford F-150 Lightning: 7,187</li>
<li>BMW i4: 7,125</li>
<li>Tesla Cybertruck: 6,406</li>
</ol>
Tesla had three of the top 10 selling models in the quarter with the Model Y and Model 3 significantly ahead of the competition. The Ford F-150 Lightning sold better than the Cybertruck in the quarter though.
What's Next: Tesla continues to be the market leader in the U.S., but its market share has fallen in recent years with increased competition and now brand power concerns.
Tesla's U.S. quarterly sales are down 26% from their peak according to the report with the company's overall U.S. auto market share now around 3%, down from 5% in 2023.
Cox Automotive predicts volatility for electric vehicles sales in the U.S. for the rest of 2025 depending on automotive tariffs and the ending of EV credits.
"The year certainly started strong, but the road ahead will be anything but smooth," Cox Automotive analyst Stephanie Valdez Streaty said.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44630769/heres-how-many-vehicles-tesla-has-delivered-produced-in-each-quarter-since-2019">Here&#8217;s How Many Vehicles Tesla Has Delivered, Produced In Each Quarter Since 2019</a></li>
</ul>
Photo: iv-olga/Shutterstock

Trading Ideas

RIVN

TSLA

Tesla Loses Steam In Q1 While US EV Sales Climb: The Winners And Losers

Citigroup analyst Andrew Kaplowitz maintains Flowserve (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLS#NYSE">FLS</a>) with a Buy and lowers the price target from $72 to $56.

Citigroup Maintains Buy on Flowserve, Lowers Price Target to $56

JP Morgan analyst Arun Jayaram expects a strong first-quarter <a target="_blank" href="https://www.benzinga.com/quote/APA/analyst-ratings" rel="noreferrer noopener">result for </a><a target="_blank" href="https://www.benzinga.com/quote/APA/analyst-ratings" rel="noreferrer noopener">APA Corporation </a><a target="_blank" href="https://www.benzinga.com/quote/APA/analyst-ratings" rel="noreferrer noopener">(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APA#NASDAQ">APA</a>)</a>.
The analyst expects overall volumes to align with the company&#8217;s guidance and sees financial results slightly ahead of Street expectations.
Jayaram forecasts adjusted oil production at 398 MBoe/d, with U.S. oil output expected to land near the lower end of the 125–127 MBoe/d guidance range.
Total volumes are expected to be slightly impacted by 11 mmcfe/d of gas/NGL shut-ins in March, roughly 73% of which is gas, due to negative Waha pricing, he added.
The analyst projects U.S. production at 298 MBoe/d in the quarter, slightly below the 300 MBoe/d guidance due to shut-ins at Alpine High.
Read: <a target="_blank" href="https://www.benzinga.com/25/03/44309792/alpha-buying-navigating-the-complex-future-of-oil-under-trumps-policy-push" rel="noreferrer noopener">Alpha Buying: Navigating the Complex Future of Oil Under Trump&#8217;s Policy Push</a>
Jayaram anticipates a capital expenditure (CAPEX) of $776 million, just above the guidance of $765 million, largely due to the timing of Suriname-related spending.
For 2025, the analyst expects the Suriname CAPEX of $200 million, with $125 million allocated in the first quarter (versus the guided $100 million).
This reflects long-cycle investment in the GranMorgu project, which aims for its first oil in 2028.
Under a scenario with WTI oil at $50 per barrel and U.S. gas at $3.50 per Mcf, Jayaram estimates free cash flow (FCF) yields of 9.2% for 2025 and 1.4% for 2026.
Finally, Jayaram projects first-quarter EPS of $0.76 vs. the Street estimate of $0.77 and EBITDAX of $1.408 billion (3% above consensus of $1.366 billion).
The company plans to release&nbsp;first-<a href="https://www.benzinga.com/earnings">quarter&nbsp;2025 results on May 8</a>.
Price Action: APA shares are down 0.03% at $15.03 at the last check on Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/04/44724489/oil-gas-stocks-jump-after-trump-pauses-tariffs-for-u-s-allies-isolates-china" target="_blank" rel="noreferrer noopener">Oil, Gas Stocks Jump After Trump Pauses Tariffs For US Allies, Isolates China</a></li>
</ul>
Photo: Shuttestock

Equities

Mid Cap

JP Morgan Expects Solid Q1 Oil Output For APA, But Sees March Shut-Ins To Impact Volumes Slightly

Citigroup analyst Andrew Kaplowitz maintains Emerson Electric (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMR#NYSE">EMR</a>) with a Buy and lowers the price target from $132 to $119.

Citigroup Maintains Buy on Emerson Electric, Lowers Price Target to $119

SWAG

Stran & Company 2024 Sales $82.7M, Up 8.8% YoY; Gross Margin 31.2%

Citigroup analyst Andrew Kaplowitz maintains Eaton Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETN#NYSE">ETN</a>) with a Buy and lowers the price target from $396 to $323.

Citigroup Maintains Buy on Eaton Corp, Lowers Price Target to $323

Health In Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIT#NASDAQ">HIT</a>) reported quarterly earnings of $0.01 per share. The company reported $8.014 million in sales this quarter.

Health In Tech Q1 2025 GAAP EPS $0.01, Sales $8.014M

Health Care

Press Releases

American Oncology Network Expands Radiation Oncology Services, Opens New Clinic

OTC Markets Group Welcomes American Oncology Network, Inc. to OTCQX

American Oncology Network Announces the Commencement of OTCQX Trading

Indianapolis Medical Oncologist Co-authors Research Presented at International Lymphoma Symposium

American Oncology Network Announces Second Quarter 2024 Earnings Release Date and Conference Call

Florida Oncology and Hematology and American Oncology Network Opens New Location in Cape Coral, Welcomes Medical Director, Dr. Van den Bergh, and Drs. Venkata Parsa, and Shivtaj Mann

American Oncology Network (AON) and Vantage Health Technologies Partner  to Improve Cancer Patient Outcomes with AI-enabled Value-Based Care Platform

American Oncology Network's Specialty Pharmacy Achieves ACHC Reaccreditation

Hematology Oncology of Indiana Physician Research Presented at 66th ASH Annual Meeting

Cancer and Blood Specialists of Arizona and American Oncology Network Welcome Dr. Ronak Rakesh Shah

AONC

OTCM

Comments

American Oncology Network

American Oncology Network (AONC) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO